Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

U.S. stock futures pointed to a steady open on Friday following record closes for the S&P 500 and the Nasdaq in the previous ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE ...

Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription ...

News government-subsidized health insurer Centene is pulling its 2025 profit outlook comes as the Republican Congress is poised to shrink the Medicaid market.

Centene (NYSE:CNC) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ...

Centene ( ($CNC) ) has released its Q2 earnings. Here is a breakdown of the information Centene presented to its investors. Centene Corporation is ...

Centene: Stock Slides as Withdrawn 2025 Guidance Adds Uncertainty to Near-Term Prospects We’ve lowered our fair value estimate and raised our Uncertainty Rating for Centene stock.